Catalytic antibodies in the bone marrow and other organs of Th mice during spontaneous development of experimental autoimmune encephalomyelitis associated with cell differentiation
暂无分享,去创建一个
S. Meuth | T. Budde | G. Nevinsky | S. Sedykh | L. Toporkova | I. Orlovskaya | V. Tereshchenko | Kseniya S Aulova | Andrey E. Urusov | Kseniya S. Aulova | S. V. Sennikov | Y. Shevchenko
[1] S. Meuth,et al. Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA–Histone complexes , 2018, Journal of cellular and molecular medicine.
[2] S. Meuth,et al. Changes in Several Disease Parameters Including Abzymes and Hematopoietic Progenitor Colony Formation in Brain Inflammation and Demyelination , 2017 .
[3] S. Meuth,et al. Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA , 2017, Journal of cellular and molecular medicine.
[4] G. Nevinsky. Catalytic Antibodies in Norm and Systemic Lupus Erythematosus , 2017 .
[5] H. Wiendl,et al. B7-H1 shapes T-cell–mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity , 2016, Proceedings of the National Academy of Sciences.
[6] G. Nevinsky. Autoimmune Processes in Multiple Sclerosis: Production of Harmful Catalytic Antibodies Associated with Significant Changes in the Hematopoietic Stem Cell Differentiation and Proliferation , 2016 .
[7] E. Granieri,et al. Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2016, PloS one.
[8] S. Meuth,et al. Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein , 2015, Journal of cellular and molecular medicine.
[9] E. Granieri,et al. Comparison of Antibodies Hydrolyzing Myelin Basic Protein from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2014, PloS one.
[10] E. Granieri,et al. Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis , 2014, PloS one.
[11] V. Buneva,et al. IgGs containing light chains of the λ- and κ- type and of all subclasses (IgG1-IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin basic protein. , 2012, International immunology.
[12] G. Nevinsky. Natural Catalytic Antibodies in Norm and in HIV-Infected Patients , 2011 .
[13] F. Kasenga. Understanding HIV/AIDS Management and Care - Pandemic Approaches in the 21st Century , 2011 .
[14] V. Buneva,et al. Affinity and catalytic heterogeneity and metal‐dependence of polyclonal myelin basic protein‐hydrolyzing IgGs from sera of patients with systemic lupus erythematosus , 2011, Journal of molecular recognition : JMR.
[15] A. Waisman,et al. Mouse models for multiple sclerosis: historical facts and future implications. , 2011, Biochimica et biophysica acta.
[16] V. Buneva,et al. Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice. , 2009, International immunology.
[17] G. Nevinsky,et al. Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors , 2007, Journal of cellular and molecular medicine.
[18] V. Buneva,et al. Antibodies with amylase activity from the sera of autoimmune‐prone MRL/MpJ‐lpr mice , 2006, FEBS letters.
[19] O. Favorova,et al. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. , 2006, Immunology letters.
[20] O. Favorova,et al. Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[21] V. Buneva,et al. Natural Catalytic Antibodies – Abzymes , 2005 .
[22] O. Favorova,et al. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis , 2004, Journal of cellular and molecular medicine.
[23] V. Buneva,et al. Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases , 2003, Journal of cellular and molecular medicine.
[24] V. A. Naumov,et al. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. , 2002, Immunology letters.
[25] H. Hartung,et al. New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.
[26] O. Favorova,et al. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. , 2001, Immunology letters.
[27] A. Bar-Or,et al. The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis , 2001, Journal of Clinical Immunology.
[28] D. Burton,et al. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Cross,et al. B cells and antibodies in CNS demyelinating disease , 2001, Journal of Neuroimmunology.
[30] H. Hartung,et al. Patients with active relapsing‐remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination , 2000, Annals of neurology.
[31] H. Hartung,et al. The role of B cells and autoantibodies in multiple sclerosis , 2000, Annals of neurology.
[32] V. A. Naumov,et al. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. , 1998, Biochemistry. Biokhimiia.
[33] I. Astsaturov,et al. Novel functional activities of anti-dna autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases , 1998, Applied biochemistry and biotechnology.
[34] Takato O. Yoshida,et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Caputo,et al. Neuroimmunology in multiple sclerosis , 1983, The Italian Journal of Neurological Sciences.
[36] Kim D. Janda,et al. Catalytic antibodies , 2007, Cell Biochemistry and Biophysics.
[37] S. Miller,et al. Experimental Autoimmune Encephalomyelitis in the Mouse , 2007 .
[38] H. Sinohara,et al. Does catalytic activity of bence-jones proteins contribute to the pathogenesis of multiple myeloma? , 2000, Applied biochemistry and biotechnology.
[39] O. Favorova,et al. [Multiple sclerosis: molecular and cellular mechanisms]. , 1995, Molekuliarnaia biologiia.